"Despite being fraught with risk, investing in biotech stocks can be highly lucrative. Michael Caldwell led a highly interactive discussion with a roomful of captivated attendees at the CFA Society Chicago Vault Series". Read the full summary here:
https://blog.cfachicago.org/2019/11/26/vault-series-counting-cards-in-biotech/
Source: CFA Society Chicago
Other Commentaries
An Alphabet Soup of Tailwinds for Industrials
By Ben Olien, CFA
How Big Pharma Merger and Acquisition (M&A) Priorities Skew the Life Sciences Investment Landscape and Create Pockets of Exploitable Inefficiency
By Alex Munns